BiotechTube
Home/Pipeline/Anti‑Obesity Oral Drug

Anti‑Obesity Oral Drug

Obesity

Phase 1Active

Key Facts

Indication
Obesity
Phase
Phase 1
Status
Active
Company
Premas Biotech

About Premas Biotech

Premas Biotech fast‑tracks biologics and vaccine development with patented platforms and end‑to‑end services.

View full company profile

Therapeutic Areas

OncologyImmunologyInfectious DiseasesMetabolic

Other Obesity Drugs

DrugCompanyPhase
LET003Harbour BioMedDiscovery
LET001Harbour BioMedDiscovery
Obesity Target Discovery CollaborationFauna BioTarget Discovery/Preclinical
GLP-1 variantsHeligenicsDiscovery
MYO Platform (Metabolic Disease)RenbioPre-clinical
Obesity Clinical TrialsIMA Clinical ResearchNot Applicable (Service)
KAYO-2000KayoTheraPreclinical
MVD-1 (SANA)Eolo PharmaPhase 1
GIP-neutralizing antibodyHelicore BiopharmaPre-clinical
Antral Gastroplasty / Endoscopic SleeveEndo-TAGSSPre-clinical
Undisclosed siRNA ProgramsMoonwalk BiosciencesPre-clinical
VIAL-INHBE (siRNA)VIAL Dermatology CROPhase 1